Guidance for healthcare professionals on risk minimisation options for medicines.
Similar Posts
Summer ready: MHRA issues updated guidance on medicines and medical devices during holiday season
As the UK enters the heart of summer – with temperatures rising and families holidaying – the Medicines and Healthcare products Regulatory Agency (MHRA) is reinforcing essential safety advice for anyone using medicines or medical devices.
Transparency data: Medicines and Healthcare products Regulatory Agency Privacy Notice
This privacy notice describes how we collect and use your personal information, in accordance with the Data Protection Act and the General Data Protection Regulation.
Field safety notices: guidance for manufacturers
How to write clear and effective field safety notices (FSNs) for medical devices.
AI tools that could detect diseases earlier selected for next phase of MHRA’s ‘AI Airlock’ programme
Seven emerging AI healthcare technologies have been selected for the second phase of the MHRA’s AI Airlock programme.
Guidance: CLOSED AI Airlock Phase 2 application
The call for applications for phase 2 of the AI Airlock is now closed.
Field Safety Notices: 19 to 23 January 2026
List of Field Safety Notices from 19 to 23 January 2026.